Eyre Katie, Whitney Diane, Mukesh Mukesh, Wilson Charles, Coles Charlotte
Department of Medical Physics, Addenbrooke's Hospital, Cambridge, UK.
Brachytherapy. 2013 Mar-Apr;12(2):107-13. doi: 10.1016/j.brachy.2012.03.010. Epub 2012 Jun 23.
This study directly compares four dosimetric techniques for balloon-based partial breast brachytherapy: single source, standard line source, and both forward planned and inverse planned multilumen (ML). A standard line source plan is presented to be used in a single catheter or as a starting point for forward planned ML.
The study population consists of 12 patients previously treated with a single lumen. Inverse plans were created for 7 patients and used to create a standard line source plan. ML plans were created on the same patient data sets. The dosimetric aims were as follows: PTV_EVAL (planning target volume for evaluation) D95 (dose received [%] by 95% of PTV_EVAL volume)≥95% of the prescribed dose (PD), the maximum skin and rib dose ≤125% of prescription dose, breast V150 (volume [cc] receiving 150% of the PD)≤50cc, and V200 (volume [cc] receiving 200% of the PD)≤10cc.
The number of patients fulfilling all dosimetric constraints went from 1 patient of 12 with a single catheter to 6 patients of 12 with inverse planned ML and 7 patients of 12 with forward planned ML. PTV_EVAL D95 increased significantly with the standard line source plans and ML plans when compared with the single-source plans. Forward planning took, on average, 7min longer than inverse planning.
Multiple sources in a single catheter improve coverage at catheter ends, whereas ML can further improve coverage and reduce dose to organs at risk. Using a standard line source as a starting point for forward planning ML means increase in planning time is kept to a minimum, making it a practicable option for centers without inverse planning software. Patients previously ineligible for treatment with a single catheter may be treated using ML.
本研究直接比较基于球囊的部分乳腺近距离放射治疗的四种剂量测定技术:单源、标准线源以及正向计划和逆向计划的多腔(ML)技术。提出一种标准线源计划,用于单导管或作为正向计划ML的起点。
研究人群包括12例先前接受单腔治疗的患者。为7例患者创建逆向计划,并用于创建标准线源计划。在相同的患者数据集上创建ML计划。剂量测定目标如下:PTV_EVAL(评估的计划靶体积)D95(PTV_EVAL体积的95%所接受的剂量[%])≥规定剂量(PD)的95%,最大皮肤和肋骨剂量≤处方剂量的125%,乳腺V150(接受150%PD的体积[cc])≤50cc,以及V200(接受200%PD的体积[cc])≤10cc。
满足所有剂量测定约束的患者数量从单导管的12例中的1例增加到逆向计划ML的12例中的6例和正向计划ML的12例中的7例。与单源计划相比,标准线源计划和ML计划的PTV_EVAL D95显著增加。正向计划平均比逆向计划多花费7分钟。
单导管中的多个源可改善导管末端的覆盖范围,而ML可进一步改善覆盖范围并降低对危险器官的剂量。使用标准线源作为正向计划ML的起点意味着将计划时间的增加保持在最低限度,使其成为没有逆向计划软件的中心的可行选择。先前不符合单导管治疗条件的患者可能可以使用ML进行治疗。